COMPANY

Breathe BioMedical

Keywords: medical device Lung Cancer Non Small Cell Lung Cancer Breast Cancer

Location: Cambridge, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Timeline

Feb 25, 2025 Trial start —: Identifying Patterns in the Breath of Individuals With Breast Cancer source ↗
Apr 24, 2023 Trial start —: Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer source ↗
Sep 22, 2022 Trial start —: Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy source ↗
Feb 25, 2021 Trial start —: Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy source ↗

2028-02 (ESTIMATED) · · Identifying Patterns in the Breath of Individuals With Breast Cancer · NCT06512350

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT06512350	Identifying Patterns in the Breath of Individuals With Breast Cancer	Not listed	Recruiting	Feb 25, 2025	2028-02 (estimated)
NCT06288646	Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer	Not listed	Terminated	Apr 24, 2023	Apr 16, 2024 (actual)
NCT05174468	Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy	Not listed	Terminated	Sep 22, 2022	Jul 12, 2023 (actual)
NCT04556435	Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy	Not listed	Terminated	Feb 25, 2021	Aug 4, 2023 (actual)